Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Transcatheter Aortic Valve Replacement With Surgical Aortic Valve Replacecment: A Prospective, Multicenter, International, Randomized Controlled, Non-inferiority Study for Bicuspid Aortic Valve Stenosis (PROMIS-BAV)

NCT06597188 is registered in ClinicalTrials.gov with Shanghai MicroPort CardioFlow Medtech Co., Ltd. as lead sponsor.

NCT NCT06597188
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06597188 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Transcatheter Aortic Valve Replacement With Surgical Aortic Valve Replacecment: A Prospective, Multicenter, International, Randomized Controlled, Non-inferiority Study for Bicuspid Aortic Valve Stenosis (PROMIS-BAV)
Lead sponsor
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
September 8, 2025
Completion date
September 30, 2032
Enrollment
452 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis, bicuspid aortic valve (bav)